Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor

Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor

Jian-De Cheng,1,* Li-Xun Chai,2,* Zhi-Ping Zhao,1 Yan-Yan Hao,1 Shuo Li3 1Department of Respiratory and Critical Care Medicine, The Shanxi Bethune Hospital, Taiyuan 030032, Shanxi, People’s Republic of China; 2Department of Thoracic Surgery, The Shanxi Bethune Hospital, Taiyuan 030032, Sha...

Full description

Bibliographic Details
Main Authors: Cheng JD, Chai LX, Zhao ZP, Hao YY, Li S
Format: Article
Language:English
Published: Dove Medical Press 2020-07-01
Series:Cancer Management and Research
Subjects:
non-small cell lung cancer
anlotinib
efficacy
safety
biomarker
Online Access:https://www.dovepress.com/efficacy-and-safety-of-anlotinib-for-patients-with-advanced-nsclc-who--peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/efficacy-and-safety-of-anlotinib-for-patients-with-advanced-nsclc-who--peer-reviewed-article-CMAR

Similar Items